Accelerated brachytherapy and chemo for advanced cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a new way of delivering radiation therapy (brachytherapy) combined with chemotherapy for advanced cervical cancer. The goal is to see if a faster, more intense radiation schedule is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are newly diagnosed with cervical cancer at a specific stage (IB3 to IVA).
- Your cancer type is one of the common types: squamous cell, adenocarcinoma, or adenosquamous.
- You have not had radiation to the pelvic area before.
- You have no other cancers that could interfere with the trial.
- You have not had a hysterectomy (removal of the uterus) or do not plan to have one as part of your initial treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a shorter, possibly more convenient schedule of pelvic radiation for advanced cervical cancer patients who cannot receive chemotherapy. The goal is to see how well this approach works and how safely it can be given when chemotherapy isn’t an option.
This trial tests a new immunotherapy drug, cadonilimab, combined with standard chemotherapy followed by chemoradiation for locally advanced cervical cancer. The goal is to see if this combination works better than current treatments.
This trial tests whether an “adaptive” type of radiation planning using proton therapy and MRI-guided brachytherapy can improve treatment for people with cervical cancer. It aims to deliver curative treatment more precisely while still combining it with chemotherapy (cisplatin) when appropriate.
This trial tests a faster, high-dose radiation treatment for cervical cancer that is given directly into the uterus. It aims to see if this approach is safe and effective for women with certain stages of the disease.
This trial tests a combination of pelvic chemoradiation (chemotherapy and radiation) with a special type of brachytherapy (internal radiation) that adjusts the dose during treatment for locally advanced cervical cancer. It aims to improve tumor control while keeping side effects manageable.
This trial tests a shorter course of radiation combined with chemotherapy and brachytherapy (internal radiation) for cervical cancer that has not spread widely. It aims to make treatment more efficient while still being effective.
Hear when a new Locally Advanced Cervical Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.